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A central question in developmental neurobiology 
concerns the mechanisms that generate cellular diversi- 
ty in the vertebrate nervous ystem. Cell lineage ana- 
lyses have established that many progenitor cells in the 
developing nervous system are multipotent (Turner 
and Cepko 1987; Holt et al. 1988; Wetts and Fraser 
1988). However, the mechanisms that control the dif- 
ferentiation of such progenitor cells are poorly under- 
stood. It is assumed that both the developmental his- 
tory of a progenitor cell and its interactions with its 
local environment influence its final choice of develop- 
mental fate. Few experimental systems are available, 
however, in which it has been possible to dissect the 
relative contributions of these two factors to the dif- 
ferentiation program. In the vertebrate nervous sys- 
tem, only two well-defined multipotential progenitor 
ceils have been isolated and studied in detail. These are 
the O2A progenitor, which gives rise to two types of 
glial cells in the central nervous system (Raft 1989), 
and the sympathoadrenal progenitor (Doupe et al. 
1985b; Anderson and Axel 1986), which generates 
either the sympathetic neurons or adrenal medullary 
chromaffin cells of the peripheral nervous system. 
The Sympathoadrenal Progenitor Has a 
Restricted Repertoire of Developmental Fates 
Sympathoadrenal progenitors derive from a popula- 
tion of neural crest cells that detach from the top of the 
neural tube and migrate throughout the embryo. 
Lineage tracing studies, performed both in vitro 
(Sieber-Blum and Cohen 1980; Baroffio et al. 1988) 
and in vivo (Bronner-Fraser and Fraser 1989), have 
indicated that single cells in the premigratory crest are 
initially multipotent and are able to generate most or all 
crest derivatives. These include not only sympathetic 
neurons and chromaffin cells, but other neuronal popu- 
lations such as sensory and parasympathetic, as well as 
nonneuronal cell types including glia and melanocytes. 
As neural crest cells migrate and localize in the 
periphery, however, they appear to become develop- 
mentally restricted, perhaps analogous to the gradual 
narrowing of the developmental potential observed in 
hematopoiesis (Anderson 1989). The sympathoadrenal 
progenitor appears to represent one such developmen- 
tally restricted progenitor cell. These progenitors are 
first detectable concomitant with the aggregation of 
crest cells to form the sympathetic ganglion primordia 
(Fig. 1). They can be visualized using several antigenic 
markers including tyrosine hydroxylase (TH), the rate- 
limiting enzyme in catecholamine biosynthesis (Coch- 
ard et al. 1979). After this initial aggregation, some of 
the cells in this population remain in the ganglion 
primordia and differentiate into sympathetic neurons, 
whereas others continue migrating ventrally to invade 
the mesodermally derived adrenal primordium (Fig. 
1). The latter proliferate and differentiate into chro- 
maffin cells, which ultimately form the medullary zone 
of the adrenal gland. 
Experiments inprimary cell culture originally suggest- 
ed that environmental factors determine the ultimate 
fate of progenitors in this sublineage. It was shown that 
postnatal (Unsicker et al. 1978) or even adult (Doupe 
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Figure 1. Schematic indicating the migratory route taken by 
cells in the sympathoadrenal lineage. A cross section through 
the spinal cord in the thoraco-lumbar region is shown. 
Cold Spring Harbor Symposia on Quantitative Biology. Volume L'~ 9 1990 Cold Spring Harbor Laboratory Press 0-87969-059-3/90 $1.00 255 
256 MORI ET AL. 
et al. 1985a) chromaffin cells could be induced to trans- 
differentiate into sympathetic neuron-like cells by 
nerve growth factor (NGF). This transdifferentiation 
could be slowed or blocked by glucocorticoid (GC), 
suggesting that the high local concentration of these 
steroids in the surrounding adrenal cortex could simi- 
larly inhibit the neuronal differentiation of chromaffin 
precursors in vivo (Unsicker et al. 1978). The idea that 
the microenvironment of sympathoadrenal lineage cells 
is important in controlling their differentiation i  vivo is 
supported by the observation that TH + cells in the 
sympathetic ganglion and the adrenal gland acquire 
distinct antigenic phenotypes only a few days after 
migration has ended (Fig. 2). 
To determine whether individual sympathoadrenal 
progenitors are bipotential, we have isolated these cells 
from fetal rat adrenal glands, using cell-surface mono- 
clonal antibodies and fluorescence-activated cell sorting 
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Figure 3. Isolation of sympathoadrenal progenitor cells from 
E14.5 rat adrenal gland by FACS using monoclona[ antibody 
HNK-I. (Top, left) Forward light scatter (abscissa) versus 
fluorescence intensity (ordinate). Gated region 2 delimits cell 
population isolated. (Top, right) Histogram of fluorescence 
intensity versus cell number. The HNK-1 + cells represent 
approximately 10% of the adrenal population. (Bottom) 
FACS-isolated progenitors several hours after plating. The 
same field is shown photographed with phase contrast optics 
(left), fluorescein-HNK-1 (middle), or rhodamine-TH (right). 
Note that all the HNK-1 + cells are also TH +. 
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Figure 2. Differential expression of antigenic markers by em- 
bryonic sympathoadrenal ce ls in the ganglion and adrenal 
primordia in vivo. Shown are sections through the caudal 
thoracic region of an E15.5 rat embryo. Cells in both the 
sympathetic ganglion (SG) and adrenal medulla (AM) stain 
with an antibody to TH (top). Note the individual cells be- 
tween the SG and AM, which may be migrating to the adre- 
nal9 (Bottom) Fluorescence photomicrographs of the same 
section dou, ble-labeled with monoclonal ntibody B2 (h,ft), 
which selectively labels primitive sympathetic neurons (An- 
derson and Axel 1986) and SA-1 (right), which selectively 
labels adrenal chromaffin cells. (J. Carnahan and P.H. Patter- 
son, unpubl.). 
(FACS) (Anderson and Axel 1986; Anderson 1988) 
(Fig. 3). In culture, the differentiation of such pro- 
genitors into chromaffin cells (Fig. 4) is absolutely 
dependent on the addition of exogenous GC to the 
culture medium (Anderson and Axel 1986; Seidl and 
Unsicker 1989; A, Michelsohn and D.J. Anderson, un- 
publ.). In the absence of GC, these progenitors initiate 
neuronal differentiation (Fig. 4), a process that can be 
promoted by specific growth factors (see below). Quan- 
titative analysis of cell populations and serial observa- 
tions of single cells strongly suggest that individual 
progenitors in these cultures are indeed bipotential 
(Anderson and Axe 1986). Similar observations have 
been made for progenitors isolated from postnatal 
(Doupe et al. 1985b) and, more recently, fetal superior 
cervical sympathetic ganglia (J. Carnahan and P.H. 
Patterson, pets. comm.). This conclusion is supported 
by recent in vivo observations showing that, in the 
ganglion primordia, chromaffin-specific and euron- 
specific markers are transiently coexpressed by in- 
dividual progenitor cells (D.J. Anderson et al., 
unpubl.). Taken together, these data suggest hat a 
common, developmentally restricted progenitor cell 
initially populates both the sympathetic ganglia and the 
adrenal gland and then differentiates into either sym- 
pathetic neurons or chromaffin cells under the influence 
of factors differentially distributed in these alternative 
sites of migratory arrest. 
NEURAL CREST CELL DIFFERENTIATION 257 
B. 
A. 
C,  
of NGF synthesis in the embryo indicated that NGF is 
unlikely to be playing such a role. NGF is initially 
produced in the targets of sympathetic innervation, ot 
in the ganglia, and is not made until the neurons have 
already grown their axons to these targets (Davies et al. 
1987; Korsching and Thoenen 1988). Moreover, freshly 
isolated sympathoadrenal progenitor cells are initially 
unresponsive to NGF in vitro (Anderson and Axel 
1986; Ernsberger et ai. 1989). Such findings have l d to 
the search for other factors that might promote neu- 
ronal differentiation i this system. 
One such factor may be fibroblast growth factor 
(FGF). FGF is the only factor other than NGF able to 
induce the expression of neuron-specific mRNAs in 
PC12 cells (Leonard et al. 1987; Stein et al, 1988a). 
Moreover, both basic (Stemple t al. 1988) and acidic 
(Claude et al. 1988) FGF can promote the trans- 
differentiation of postnatal chromaffin cells into neu- 
rons. However, FGF cannot act subsequently asa sur- 
vival factor for the sympathetic neurons generated from 
chromaffin cells. Rather, FGF induces an NGF depen- 
dence in these cells (Stemple et al. 1988). Taken to- 
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Figure 4. FACS-isolated progenitors develop into sym- 
pathetic neurons or chromaffin cells, in vitro. (A) Phase- 
contrast micrograph of progenitor cells after 24 hours in cul- 
ture. (--~) Note the short cytoplasmic extensions characteristic 
of such cells. (B) Progenitors after 2-3 days in serum-contain- 
ing medium. Under these conditions, the cells begin to dif- 
ferentiate into neurons, extending short neurites, but they 
eventually die. Neurite extension is enhanced by addition of 
FGF (not shown). (C) Progenitors after 2-3 days in 5 txM 
dexamethasone. Note the difference in morphology from the 
cells in B. Cells in both B and C are labeled with an anti-TH 
antibody. However, cells such as those in B also express 
neurofilaments, whereas those in C xpress the chromaffin 
marker PNMT (not shown). B. 
DEX 
Neuronal Differentiation of Sympathoadrenal 
Progenitors May Be Controlled by Polypeptide 
Factors Acting in a Cascade 
The requirement of GC for chromaffin cell differen- 
tiation in vitro is consistent with the fact that in vivo 
these cells normally develop within the adrenal gland, 
the major site of GC synthesis. In contrast, he identifi- 
cation of factors promoting neuronal differentiation 
and their relationship to molecules present in vivo has 
been more difficult to establish. As NGF converts both 
chromaffin cells (Unsicker et al. 1978) and PC12 cells 
(Greene and Tischler 1976) into sympathetic neuron- 
like cells, this molecule initially seemed like a reason- 
able candidate for the factor that promotes neuronal 
differentiation of sympathetic neuroblasts in vivo. 
However, subsequent studies of the timing and location 
FGF + NGF 
Figure 5. Immortalized sympathoadrenal progenitor cells can 
differentiate into stable, postmitotic neurons. (A) MAH cells 
maintained in 5 /xM dexamethasone. Note the morphologic 
similarity to the primary cells shown in Fig. 4A. (B) A small 
proportion (< 0.1%) of MAH cells develop into neurons in 
the presence of bFGF (10 ng/ml)+ NGF (50 ng/ml). The 
cells shown had been maintained for approximately 4 weeks in 
culture at the time this photograph was taken. The magnifica- 
tion in A is twice that in B. 
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gether, these results suggested a potential role for FGF 
in the initial stages of neuronal differentiation i the 
sympathoadrenal lineage. 
To address this question, we first generated immortal 
cell lines from sympathoadrenal progenitors by re- 
troviral transduction of the v-myc oncogene (Fig. 5A). 
These lines appear to have retained many of the mor- 
phologic and antigenic properties of their normal (i.e., 
nonimmortalized) counterparts (Birren and Anderson 
1990). Such cell lines facilitate cell biological and 
molecular experiments by providing large numbers of 
easily available cells. We have named these cell lines 
MAH cells, for myc-infected, adrenal-derived, HNK- 
1-positive cells (Birren and Anderson 1990). MAH 
cells represent he first case where a well-defined 
neuronal progenitor population has been first isolated 
and then immortalized. 
A striking feature of MAH cells is that they respond 
to basic FGF (bFGF) by extending long neurites, but 
they do not do so in response to NGF. This is because 
these cells do not express the NGF receptor (NGFR), 
as determined by hybridization of MAH cell mRNA 
with cloned NGFR eDNA probes (Birren and Ander- 
son 1990). Like normal chromaffin cells, MAH cells 
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Figure 6. Stages of neuronal differentiation in the sympatho- 
adrenal lineage. The sympathoadrenal progenitors represent- 
ed by MAH cells (top) extend neurites in response to FGF 
but do not yet express NGF receptors. In the presence of 
glucocorticoid, these cells divide (circular arrow) but do not 
differentiate. Following treatment with FGF, a primitive 
neuron can be observed that bears processes and i  till divid- 
ing. This cell type has been described in primary cultures 
previously (Anderson a d Axel 1986; Anderson 1988). At 
least a subpopulation of these primitive neurons begins to 
express the NGF receptor. In the presence of NGF, these cells 
mature into postmitotic neurons with large cell bodies, promi- 
nent nucleoli, and extensive networks of neurites. Such neuro- 
ns are then dependent on NGF for survival. (Reprinted, with 
permission, from Birren and Anderson 1990.) 
induced to differentiate with FGF alone die several 
days after extending neurites. In the presence of both 
FGF and NGF, however, a small proportion of MAH 
cells become postmitotic neurons that are stable for 
many weeks in culture if supplied with NGF (Fig. 5B). 
In the presence of a blocking anti-NGF antibody, how- 
ever, these MAH-derived neurons rapidly die, indicat- 
ing that they are now dependent on the neurotrophic 
factor for survival. Northern blot analysis has confir- 
med that treatment of MAH cells with FGF induces the 
de novo expression of NGFR mRNA (Birren and An- 
derson 1990). 
Taken together, these data suggest hat neuronal 
development in this lineage may involve a relay, or 
cascade, in which one factor (perhaps FGF) initiates 
differentiation and simultaneously primes the cell to 
respond to a second factor (NGF), which then sub- 
serves further maturation and survival (Fig. 6). The 
extent o which FGF exerts such an effect on normal 
progenitors i now under investigation. Interestingly, 
when cultured athigh density, such progenitors appear 
to initiate neuronal differentiation spontaneously. Such 
an effect could be due to an autocrine action of FGF or 
an FGF-like molecule. Whatever the case, the data 
suggest that the initial stages of neuronal differentiation 
in this lineage occur independently of NGF (Coughlin 
and Collins 1985) but involve an induction of the 
NGFR. As NGF appears able to up-regulate xpres- 
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Figure 7. A two-stage model for sympathetic neuron develop- 
ment. (Top) FGF (or a different factor with similar biological 
activity) induces progenitor proliferation and neuronal dif- 
ferentiation locally in the sympathetic ganglion primordia. 
These differentiating cells extend processes toward their 
targets. The appearance of NGF in targets coincides with the 
arrival of the sympathetic afferent ib rs. At or near the 
target, neurons acquire responsiveness to and dependence on 
NGF, which thereby supports their survival and further matu- 
ration. (Bottom) In the adrenal gland, GC permits FGF to 
mitotically expand the developing endocrine population but 
prevents the factor from inducing neuronal differentiation. 
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sion of its own receptor (at least in PC12 cells; Doherty 
et al. 1988), it may be that the initiating factor simply 
provides sufficient NGFR to establish an NGF au- 
toregulatory loop that is in turn primarily responsible 
for the induction of full NGF-responsiveness and NGF- 
dependence. 
This "two-factor" model would fit well with the fact 
that, in vivo, neuronal differentiation is initiated at a 
site (the ganglia) distant from that where NGF is even- 
tually synthesized (Korsching and Thoenen 1988) (Fig. 
7). According to this view, FGF (or a molecule with 
similar biological activity) would act locally in the gan- 
glia to trigger initial neurite outgrowth. At the same 
time, the induction of NGFR expression would ensure 
that by the time the growing axons arrived at the 
periphery, they would have acquired competence to be 
supported by target-derived NGF. Moreover, the in- 
duction of an absolute NGF dependence in these grow- 
ing neurons would ensure the death of any cells that 
failed to grow to an appropriate target. Studies are now 
in progress to determine whether mRNAs encoding 
FGF or related members of the FGF gene family 
(Hdbert et al. 1990) are indeed present in embryonic 
sympathetic ganglia at the stage when neuronal dif- 
ferentiation normally occurs. Recent immunocyto- 
chemical evidence suggests that bFGF, at least, is pre- 
sent in embryonic hick sympathetic neurons (Kalcheim 
and Neufeld 1990). 
Derepression of Neural-specific Genes May Be a 
Developmental Prerequisite for Their Regulation 
by Environmental Factors 
The foregoing data indicate that the development of
sympathoadrenal derivatives occurs through the action 
of diffusible factors on a progenitor cell with a re- 
stricted repertoire of developmental fates. Studies of 
gene expression in PC12 cells indicate that, at the 
molecular level, these factors act by up- and down- 
regulating terminal-differentiation ge es specific to the 
neuronal and chromaffin phenotypes, respectively 
(Leonard et al. 1987; Stein et al. 1988a). In other 
words, NGF and FGF induce neuron-specific genes and 
suppress chromaffin-specific genes, and vice versa for 
GC. The "repertoire of fates" in a committed sym- 
pathoadrenal progenitor cell is therefore reflected 
molecularly in batteries of neuron-specific and 
chromaffin-specific genes that can be activated or re- 
pressed by FGF/NGF and GC. The question thus is how 
this repertoire first becomes established in the pro- 
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Figure 8. Identification of two DNase 1 HSS in the SCG10 gene that are lineage-specific. (A, B, C) Southern blots of 
DNase-l-digested, BgllI-restricted genomic DNA from adult AM (A), E18 brain (B), and liver (C). The two HSS are indicated 
by the presence of the two subbands running at 1.8 and 2 kb (A and B, arrowheads). The arrow p inting down indicates the 8-kb 
BgllI parent band (A). The faint band at -3  kb (asterisk) represents cross-hybridization of the probe to the immediately 
upstream BglII fragment, due to a repeat sequence. (D) Schematic illustrating the location of the sites in the SCG10 gene. ( I )  
Coding exons; ([]) noncoding exons. The complete intron-exon organization of this gene has not been determined. Vertical ines 
demarcate he 8-kb BgllI parent band containing the HSS. The size and location of the probe are indicated. (Reprinted, with 
permission, from Vandenbergh et al. 1989.) 
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Figure 9. Schematic illustrating SCG10-CAT gene fusion constructs used to generate transgenic mice+ The "proximal" region in 
CAT4 extends from a PvuII site in the 5'-untranslated r gion of the mRNA to an EcoRI site - 0.5 kb upstream. The distal region 
in CAT37 contains an additional 3.7 kb of 5'-flanking DNA. CAT30 is 0.7 kb shorter than CAT37 at its 5' end. The number of 
independent i egrants generated for each construct is indica ed. For each integrant, between 1 and 30 copies of the gene were 
present. (Reprinted, with permission, from Wuenschell et al. 1990.) 
genitor cell. The determination of this repertoire is 
presumably closely related to the commitment of early 
neural crest cells to the sympathoadrenal sublineage. 
Both FGF and GC are factors that exert a broad 
range of effects on cells of different lineages through 
the activation of transcription factors. In the case of 
GC, the receptor itself is a transcription factor (Chan- 
dler et al. 1983); in the case of FGF (and NGF), the 
receptors activate transcription factors indirectly via 
second messenger pathways (Sheng and Greenberg 
1990). The specificity of action of these factors on cells 
of a given lineage must therefore be determined, at 
least in part, by the set of target genes that their 
corresponding transcription factors can activate or re- 
press. One mechanism that has been proposed to ac- 
count for the selectivity of target gene activation is the 
accessibility of such genes to transcription factors in 
chromatin (Robins et al. 1982; Burch and Weintraub 
1983). According to this view, the repertoire of fates 
available to a sympathoadrenal progenitor cell would 
be established as a set of genes maintained in a 
chromatin configuration accessible to transcription fac- 
tors activated by FGF and/or GC (Anderson and Axel 
1985). 
As an initial test of this hypothesis, we examined the 
chromatin structure of a neuron-specific gene that can 
be induced by FGF or NGF in sympathoadrenal ce ls. 
This gene, SCG10, encodes a 22-kD vesicle-associated 
protein that accumulates in the growth cones of de- 
veloping and regenerating eurons (Stein et al. 1988b). 
We examined SCG10 chromatin structure in adult ad- 
renal chromaffin cells because these cells retain the 
capacity to transdifferentiate into neurons in response 
to FGF or NGF, and because SCG10 is induced uring 
this transdifferentiation (A derson and Axel 1985). As 
an index of an accessible or "open" chromatin struc- 
ture, we used the well-established criterion of sensitivi- 
ty to digestion by DNase I (Gross and Garrard 1988). 
We found that SCG10 exhibits a specific pattern of 
DNase I hypersensitivity n the nuclei of adult chromaf- 
fin cells (Vandenbergh et al. 1989). This pattern, 
marked by two cleavage sites in the promoter region of 
the gene (Fig. 8A), is also found in neurons expressing 
high levels of SCG10 (Fig. 8B) but not in nonneuronal 
cells (Fig. 8C). Thus, these hypersensitive sites appear 
to define a state of the SCG10 gene that ischaracteristic 
of both neurons and chromaffin cells and is therefore 
independent of whether or not the gene is expressed at 
high levels. We anticipate but have not yet proven that 
these sites appear in ontogeny at the time that neural 
crest cells initially commit to the sympathoadrenal 
lineage, since this is the earliest ime that the SCG10 
gene is detectably transcribed (Anderson and Axel 
1986). The persistence of this DNase-sensitive 
chromatin structure in adult chromaffin cells, more- 
over, could in part account for the phenotypic plasticity 
exhibited by these cells (Vandenbergh et al. 1989). 
To gain further insight into the mechanisms control- 
ling the assembly of this state of the SCG10 gene, we 
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Figure 10. Neuron-specific expression of CAT37 and CAT30 
in transgenic mice. Two representative integrants for CAT30 
(A, B) and CAT37 (C, D) are shown. CAT enzymatic activity 
was assayed using 50 k~g of protein from the indicated adult 
tissues: (B) brain; (Lv) liver; (K) kidney; (H) heart; (Lg) 
lung; (S) spleen; (A) adrenal gland. (A, B) 40 p,g of adrenal 
gland protein was used. Note that in the two lines expressing 
the highest levels of CAT in brain (A, C) a low level of 
expression is also detected in the adrenal gland. (Reprinted, 
with permission, from Wuenschell et al. 1990.)
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have examined the formation of the hypersensitive sites 
in transgenic mice (Wuenschell et al. 1990). We gener- 
ated several mice containing varying lengths of SCG10 
5'-flanking DNA fused to the heterologous reporter 
gene CAT (bacterial chloramphenicol acetyltransfer- 
ase) (Fig. 9). All of these gene fusion constructs con- 
tained the proximal region of the SCG10 promoter to 
which the DNase-I-hypersensitive sites map in the en- 
dogenous gene. However, these constructs varied in 
the amount of SCG10 DNA lying upstream of this 
region (Fig. 9). 
We found that 3.5 kb of SCG10 5'-flanking DNA 
appeared sufficient o reconstitute correctly the pattern 
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Figure l l .  Formation of the HSS in transgenic mice contain- 
ing SCGI0-CAT gene fusion constructs. The HSS were as- 
sayed in the brains (A, C) and livers (B, D) of two transgenic 
mice expressing either the transgene SCG10-CAT4 (A, B) or 
SCG10-CAT37 (C, D). The structure of these two gene fusion 
constructs relative to the endogenous SCG10 gene is illus- 
trated below the Southern blots. Note that the twin HSS map 
within the proximal regulatory region contained within both 
transgene constructs. CAT4 (A, B), which contains only the 
450-bp proximal regulatory region, contains the HSS in both 
tissues (A, B, horizontal arrows). CAT37 (C, D), which 
contains the entire 4-kb 5' region of SCG10, is expressed in 
brain nuclei but not liver nuclei and contains the HSS only in 
brain nuclei (C, horizontal arrows). The band at ~3 kb 
reflects a weak HSS that is also present in the endogenous 
gene but is not tissue-specific (data not shown). The probe 
used (schematic) contains only CAT coding DNA and there- 
fore detec~ only the transgene on these Southern blots. Two 
parent bands are detected in the CAT4 mouse (A, B, ar- 
rowheads) due to the tandem ligation of two copies of the 
transgene. A single band is detected for the CAT37 mouse. 
(Reprinted, with permission, from Vandenbergh etal. 1990.) 
of endogenous SCG10 gene expression, at least at the 
gross tissue level (Wuenschell et al. 1990). A high level 
of transcription was detected in brain tissue, a very low 
level in adrenal gland tissue, and no expression in 
various nonneuronal tissues (Fig. 10). Importantly, in 
these mice, the two DNase-hypersensitive sites formed 
in their characteristic position in the transgene in a 
neuron-specific manner (Fig. l lC ,D)  (Vandenbergh et 
al. 1989). Surprisingly, deletion of the distal region of 
the SCG10 5'-flanking DNA (Fig. 9, CAT4) resulted in 
deregulated expression of the transgene (Fig. 12A-C).  
In these mice, moreover, the hypersensitive sites 
formed in their characteristic position in liver, an inap- 
propriate tissue, as well as in brain tissue (Fig. l lA ,B) .  
These results suggested that the two hypersensitive 
sites reflect a state of the SCG10 gene that can, in 
principle, form in any cell type. The formation of this 
state is apparently blocked in nonneuronal cells by 
sequences lying upstream of the proximal hypersensi- 
tive region. In an independent set of transient expres- 
sion experiments (Mori et al. 1990), we showed that 
this upstream region has the properties of a silencer, 
which strongly suppresses transcription from the 
SCG10 promoter in nonneuronal,  but not in neuronal- 
cell lines (Fig. 13). This silencer, moreover, can act in 
an orientation-independent a d relatively position- 
insensitive manner to suppress transcription from a 
heterologous promoter as well (Fig. 14). 
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Figure 12. SCGIO-CAT constructs lacking the distal silencer 
region exhibit deregulated expression in transgenic mice. 
Shown are CAT assays from three different integrants harbor- 
ing the CAT4 construct in A, B, and C, respectively. In D, a 
nontransgenic control is shown. Tissue abbreviations are the 
same as those in Fig. 10. Note that varying levels of CAT 
activity can be detected in some or all nonneuronal tissues in 
all three transgenic mice. Quantitative analysis of such assays 
indicates that despite their loss of tight tissue specificity, the 
relative level of CAT activity is always highest in brain tissue 
for each mouse (Wuenschell et al. 1990), 
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Figure 13. Identification of a constitutive nhancer in the 
proximal region and of a cell-preferred silencer in the distal 
region. (A) Representative CAT enzymatic activity assays 
from an experiment in which the indicated constructs were 
transfected into HeLa and PC12 cells, in parallel. CAT3 con- 
tains the promoter-proximal region and is similar to CAT4 
(Fig. 9). Note that the activity of CAT3 is comparable to that 
of RSV-CAT in both HeLa and PC12 cells, and that CAT37 
and CAT16 arc strongly suppressed in HeLa cells relative to 
CAT3. (B) Quantification of the suppression activity. CAT 
activity was normalized to that of the cotransfected internal 
control plasmid, pRSVlacZ. The activity of CAT3 (or CAT4) 
was set at 100%, and the fractional activity shown by the other 
constructs was calculated. The data shown are the mean -+ 
range of two independent experiments. (C) Suppression by 
CAT37 and CAT16 is stronger in HeLa cells than in PC12 
cells. Fold suppression was calculated for each construct in 
each cell line as the reciprocal of the activity relative to CAT3 
(from B above). The ratio of this value for HeLa and PC12 
cells was then calculated. Thus, for example, CAT37 is sup- 
pressed 55-fold in HeLa cells and 2.8-fold in PC12 cells (rela- 
tive to CAT3), so the ratio of old suppression is 19.4. (Re- 
printed, with permission, from Mori et al. 1990.) 
Since deletion of the silencer permits an SCG10 
transgene to assume an accessible chromat in configura- 
t ion in an inappropr iate tissue, it is reasonable to con- 
clude that the endogenous gene acquires this configura- 
tion during normal development  because of the loss or 
inactivation of proteins that interact with the silencer. 
Thus, the open state of the SCG10 gene in sympatho- 
adrenal progenitors may reflect the fact that this gene 
has undergone a specific derepression event (Fig. 15). 
It is not clear whether  this derepression occurs by an 
actual "open ing"  of chromat in or simply by the relief 
0 
O000O 
Figure 14. Orientation-independent inhibition of transcrip- 
tion from a heterologous promoter by the SCG10 silencer 
element, The constructs hown were assayed by transient 
transfection in HeLa cells. TKCAT contains the HSV TK 
promoter to position -109 (McKnight and Kingsbury 1982). 
SCG10CAT 16(+) contains 1.6 kb of SCG10 DNA located 
immediately upstream of the proximal promoter-enhancer r - 
gion contained in CAT4 (for details, see Mori et al. 1990). 
Note that in either orientation, this DNA suppresses transcrip- 
tion from the TK promoter. 
ISCG10 R~P~ED]  
N~NoN~N&~ ~"~,~ OTHER NEURONS 
[SCG 10 ,RF.P.R~SSEDI [SCG I 0 D.I~.F.,PRF, SSED, 
INDUCED] 
SYMPATHOADRENAL PROGENITOR 
[SCG J O DERF. ,P~,  UNINDUCED] 
CHROMAFFIN CELL SYMPATHETIC NEURON 
[SCG 10 DERF~RESSED, [SCG10 DERF~RESSED, 
SUPPRESSED BY GC] INDUCED BY NGF&FGF] 
Figure 15. Model to suggest he role of the silencer dement 
during neuronal lineage diversification. Early neuroepithelial 
precursor cells maintain the SCG10 gene in a repressed state. 
With the appearance of committed sympathoadrenal pro- 
genitor cells, the gene becomes derepressed as a result of 
functional inactivation of the silencer. Such a derepression 
also occurs in other neuronal lineages. In nonneuronal 
lineages, SCGI0 remains in a repressed state. Later in sym- 
pathoadrenal development, the gene is either further induced 
by FGF and NGF in sympathetic neurons or suppressed by 
GC in adrenal chromaffin cells. This induction or suppression 
is superimposed on the derepressed state of the gene. Note 
that cells indicated in white letters are those in which the 
silencer is active; those indicated in black are cells in which the 
silencer is inactive. (Reprinted, with permission, from Mori et 
al. 1990.) 
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from a repression imposed by sequence-specific si- 
lencer-binding factors. Whatever the case, we imagine 
that such a derepression is a prerequisite for the sub- 
sequent modulation (Stein et al. 1988a) of SCG10 ex- 
pression by FGF/NGF and GC. It is likely, however, 
that the acquisition of such a derepressed state is insuf- 
ficient to confer full regulatability on these genes. Pro- 
genitor cells must also acquire receptors for FGF and 
NGF,  as well as signal-transduction components and 
transcription factors that specifically interact with the 
SCG10 gene in its derepressed state. Nevertheless, we 
believe that the derepression of SCGI0 may define an 
important developmental step, in which an apparently 
cell-intrinsic mechanism affects the genomic response 
of a progenitor cell to a set of specific environmental 
influences. An understanding of the mechanism of 
SCG10 derepression may therefore yield insights into 
the molecular basis for the segregation of neural crest 
cells into the sympathoadrenal and other neuronal sub- 
lineages. 
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